Delex Pharma International, Inc. (DPI) is a proud Filipino-owned and managed pharmaceutical and medical device company. It was established in 2009, inspired by its vision to provide patients with an alternative choice to quality and affordable products due to the rising cost of medication in the ICU setting.

The core leaders' motivation in starting the company draws from their aspiration to create job opportunities for the Filipino people so that leaving the country will be their last option. As Filipinos, they understand the value of family and the presence of each member as a support system that can bring a positive impact on nation-building. Inspired by their nationalistic views and with the help of some doctors who believed in their goals, they started the company manned by 23 people in its first year of operation.

Delex launched the now power brands of the company, which created an excellent impression on its clientele. Thus, it gained a notable presence in the pharmaceutical industry. Totilac and Norepin became an emblem of what Delex stands for in bridging the gaps of the challenges experienced by patients in the ICU—no or few alternative drugs that help save critically ill patients' lives. Likewise, the rising cost of medications and the unavailability of some critical care drugs pose challenges to severely ill patients. Hence, the Delex tagline of "meeting the gaps in critical care" was born.

Delex is here as we value life and every member of your family!